Summary MetaStat Inc (MetaStat) is a molecular diagnostic company that develops and commercializes best-in-class diagnostic tests for prediction and treatment of systemic metastasis. The company offers products such as MetaSite Breast, developed to predict the spread of cancer through the bloodstream to other organs; and MenaCalc Lung, a test evaluated to predict the likelihood of metastasis in adenocarcinoma of the lung. MetaStat also provides MenaCalc Prostate, a diagnostic for prostate cancer; and MenaBloc, a platform technology that develops therapies that can preemptively reduce or eliminate metastasis. Its technologies are based on the roles of both the tumor microenvironment and the expressions of the Mena protein and its isoforms in the development of metastatic disease. The company develops its products using mena protein, a potentiator and modulator of cellular migration. MetaStat is headquartered in Boston, Massachusetts, the US. MetaStat Inc (MTST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on... Research Beam Model: Research Beam Product ID: 2114199 250 USD New
MetaStat Inc (MTST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

MetaStat Inc (MTST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : September   2017
  • Pages : 28
  • Publisher : GlobalData
 
 
 
Summary

MetaStat Inc (MetaStat) is a molecular diagnostic company that develops and commercializes best-in-class diagnostic tests for prediction and treatment of systemic metastasis. The company offers products such as MetaSite Breast, developed to predict the spread of cancer through the bloodstream to other organs; and MenaCalc Lung, a test evaluated to predict the likelihood of metastasis in adenocarcinoma of the lung. MetaStat also provides MenaCalc Prostate, a diagnostic for prostate cancer; and MenaBloc, a platform technology that develops therapies that can preemptively reduce or eliminate metastasis. Its technologies are based on the roles of both the tumor microenvironment and the expressions of the Mena protein and its isoforms in the development of metastatic disease. The company develops its products using mena protein, a potentiator and modulator of cellular migration. MetaStat is headquartered in Boston, Massachusetts, the US.

MetaStat Inc (MTST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MetaStat Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MetaStat Inc, Medical Devices Deals, 2011 to YTD 2017 9
MetaStat Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MetaStat Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 11
Licensing Agreements 12
ASET Therapeutics Enters into Licensing Agreement with MetaStat 12
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 14
Equity Offering 16
MetaStat Raises USD0.4 Million in Second Tranche of Private Placement of Shares and Preferred Shares 16
MetaStat Raises USD2.1 Million in First Tranche of Private Placement of Shares and Preferred Shares 17
MetaStat Raises USD2.1 Million in Final Tranche of Private Placement of Series B Preferred Shares 18
MetaStat Completes Private Placement Of Shares For US$0.81 Million 20
Acquisition 21
PhotoVoltaic Solar Cells Acquires MetaStat, Life Science Company 21
MetaStat Inc - Key Competitors 22
MetaStat Inc - Key Employees 23
MetaStat Inc - Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Aug 03, 2017: MetaStat Welcomes Renato T. Skerlj, Ph.D., Accomplished Drug Developer to Its Scientific and Clinical Advisory Board 25
May 08, 2017: MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. to Chairman of the Board and Appoints Douglas A. Hamilton, MetaStat’s President and CEO to its Board of Directors 26
Apr 27, 2016: MetaStat Appoints Jerome B. Zeldis, M.D., Ph.D. to its Board of Directors 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
MetaStat Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MetaStat Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MetaStat Inc, Deals By Therapy Area, 2011 to YTD 2017 8
MetaStat Inc, Medical Devices Deals, 2011 to YTD 2017 9
MetaStat Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 11
ASET Therapeutics Enters into Licensing Agreement with MetaStat 12
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 14
MetaStat Raises USD0.4 Million in Second Tranche of Private Placement of Shares and Preferred Shares 16
MetaStat Raises USD2.1 Million in First Tranche of Private Placement of Shares and Preferred Shares 17
MetaStat Raises USD2.1 Million in Final Tranche of Private Placement of Series B Preferred Shares 18
MetaStat Completes Private Placement Of Shares For US$0.81 Million 20
PhotoVoltaic Solar Cells Acquires MetaStat, Life Science Company 21
MetaStat Inc, Key Competitors 22
MetaStat Inc, Key Employees 23
List of Figures
MetaStat Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MetaStat Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MetaStat Inc, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter